Wellgistics Health Q2 2025 results: H1 pro forma revenue $18.65M, debt conversion strengthens balance sheet

Wellgistics Health, Inc.

2025-Q2 EPS reported -$0.69 revenue$18,654,308

Pro forma revenue for H1 2025 was $18.65M, up 2.2% from $18.25M in H1 2024.
Converted $10.1M of debt into common stock equity (including $8.6M after June 30) to improve balance sheet flexibility.
Completed operational integration of Wellgistics LLC and Wood Sage LLC, reduced SG&A, upgraded ERP system.
Appointed UHY LLP, a PCAOB-registered auditor, which completed Q2 review; advancing SOC 2 certification.
Expanding DTP programs in diabetes, weight loss, chronic pain; network includes 6,500+ pharmacies and 200 manufacturers.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.